LevelJump Announces 2025 Third Quarter Results
LevelJump (OTC: JMPHF) reported Q3 2025 results for the three and nine months ended September 30, 2025. Q3 revenue was $4.84M, up 8.7% year‑over‑year, and nine‑month revenue was $14.1M, up 9.1% year‑over‑year. The company reported a Q3 net loss of $(26,378) and nine‑month net income of $5,754. Consolidated Q3 EBITDA was $600,677 and nine‑month EBITDA was $1.90M. The 100% owned subsidiary Canadian Teleradiology Services generated Q3 EBITDA $836,000 and nine‑month EBITDA $3.04M. A previously announced acquisition of two Calgary clinics was terminated after landlord approval was not obtained. Management cited organic clinic growth and service expansion plans in Alberta.
LevelJump (OTC: JMPHF) ha riportato i risultati del Q3 2025 per i tre e i nove mesi chiusi al 30 settembre 2025. Il fatturato del Q3 era $4,84 milioni, in crescita dell'8,7% su base annua, e il fatturato dei nove mesi era $14,1 milioni, in aumento del 9,1% su base annua. La società ha registrato una perdita netta del Q3 di $(26,378) e un utile netto dei nove mesi di $5,754. L'EBITDA consolidato del Q3 è stato $600.677 e l'EBITDA dei nove mesi è stato $1,90 milioni. La controllata al 100% Canadian Teleradiology Services ha generato un EBITDA del Q3 di $836.000 e EBITDA dei nove mesi $3,04M. Un'acquisizione precedentemente annunciata di due cliniche a Calgary è stata terminata dopo che non è stata ottenuta l'approvazione del locatore. Il management ha citato la crescita organica delle cliniche e piani di espansione dei servizi in Alberta.
LevelJump (OTC: JMPHF) informó los resultados del tercer trimestre de 2025 para los tres y nueve meses terminados el 30 de septiembre de 2025. Los ingresos del Q3 fueron $4.84M, un aumento del 8,7% interanual, y los ingresos de los nueve meses fueron $14.1M, un incremento del 9.1% interanual. La empresa reportó una pérdida neta del Q3 de $(26,378) y un ingreso neto de los nueve meses de $5,754. El EBITDA consolidado del Q3 fue de $600,677 y el EBITDA de nueve meses fue de $1.90M. La filial 100% propietaria Canadian Teleradiology Services generó un EBITDA del Q3 de $836,000 y EBITDA de nueve meses $3.04M. Una adquisición previamente anunciada de dos clínicas en Calgary fue terminada tras no obtenerse la aprobación del arrendador. La gerencia citó crecimiento orgánico de las clínicas y planes de expansión de servicios en Alberta.
레벨점프(LevelJump) (OTC: JMPHF) 는 2025년 9월 30일 종료된 3개월 및 9개월 실적을 2025년 3분기에 대해 발표했습니다. 제3분기 매출은 $4.84M으로 전년 동기 대비 8.7% 증가했고, 9개월 매출은 $14.1M으로 전년 동기 대비 9.1% 증가했습니다. 회사는 제3분기 순손실 $(26,378) 및 9개월 순이익 $5,754를 보고했습니다. 통합 제3분기 EBITDA는 $600,677이고 9개월 EBITDA는 $1.90M입니다. 100% 지분의 자회사 Canadian Teleradiology Services 는 제3분기 EBITDA $836,000 및 9개월 EBITDA $3.04M를 창출했습니다. 칼거리의 두 개 클리닉에 대한 앞서 발표된 인수는 임대인 승인 미취득으로 종료되었습니다. 경영진은 앨버타 주의 클리닉 성장과 서비스 확장 계획을 언급했습니다.
LevelJump (OTC: JMPHF) a publié les résultats du T3 2025 pour les trois et neuf mois clos le 30 septembre 2025. Le chiffre d'affaires du T3 était de $4,84M, en hausse de 8,7% d'une année sur l'autre, et le chiffre d'affaires des neuf mois était de $14,1M, en progression de 9,1% d'une année sur l'autre. La société a enregistré une perte nette du T3 de $(26 378) et un bénéfice net sur neuf mois de $5 754. L'EBITDA consolidé du T3 était de $600 677 et l'EBITDA des neuf mois était de $1,90M. La filiale détenue à 100% Canadian Teleradiology Services a généré un EBITDA du T3 de $836 000 et un EBITDA des neuf mois de $3,04M. Une acquisition de deux cliniques à Calgary annoncée précédemment a été résiliée après que l'approbation du bailleur n'a pas été obtenue. La direction a cité la croissance organique des cliniques et les plans d'expansion des services en Alberta.
LevelJump (OTC: JMPHF) hat die Ergebnisse für Q3 2025 für die drei und neun Monate zum 30. September 2025 bekannt gegeben. Q3-Umsatz betrug $4,84M, ein Anstieg um 8,7% gegenüber dem Vorjahr, und Umsatz der neun Monate betrug $14,1M, ein Anstieg um 9,1% gegenüber dem Vorjahr. Das Unternehmen meldete einen Q3-Nettoverlust von $(26.378) und ein Nettoeinkommen der neun Monate von $5.754. Das konsolidierte Q3-EBITDA betrug $600.677 und das EBITDA der neun Monate betrug $1,90M. Die 100%-Tochter Canadian Teleradiology Services generierte im Q3 ein EBITDA von $836.000 und in neun Monaten ein EBITDA von $3,04M. Eine zuvor angekündigte Übernahme von zwei Kliniken in Calgary wurde beendet, nachdem die Vermieter-Genehmigung nicht eingeholt wurde. Das Management verwies auf organisches Klinikwachstum und Expansionspläne der Dienstleistungen in Alberta.
LevelJump (OTC: JMPHF) أبلغت عن نتائج الربع الثالث من 2025 للثلاثة أشهر ومدة التسعة أشهر المنتهية في 30 سبتمبر 2025. كان إيراد الربع الثالث $4.84M، بزيادة قدرها 8.7% على أساس سنوي، وكان إيراد الأشهر التسعة $14.1M، بزيادة قدرها 9.1% على أساس سنوي. وسمت الشركة خسارة صافية للربع الثالث بقيمة $(26,378) وصافي دخل الأشهر التسعة بقيمة $5,754. كان EBITDA الموحد للربع الثالث $600,677 وEBITDA للأشهر التسعة $1.90M. حققت الشركة التابعة المملوكة بنسبة 100% Canadian Teleradiology Services EBITDA للربع الثالث قيمته $836,000 وEBITDA للأشهر التسعة قيمته $3.04M. تم إنهاء الاستحواذ المعلن عنه سابقاً على عيادتين في كالغري بعد عدم الحصول على موافقة المالك. أشارت الإدارة إلى النمو العضوي للعيادات وخطط توسيع الخدمات في ألبرتا.
- Q3 revenue +8.7% to $4.84M
- Nine‑month revenue +9.1% to $14.1M
- Canadian Teleradiology Q3 EBITDA $836,000
- Nine‑month consolidated EBITDA $1.90M
- Q3 net loss of $(26,378)
- Nine‑month net income only $5,754
- Planned acquisition of two Calgary clinics terminated due to landlord non‑approval
Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its financial results for the three months and nine months ended September 30, 2025.
Financial and Operational Highlights
Revenues were
$4.84 million in the third quarter compared to$4.45 million in the same period the prior year, an increase of8.7% .For the nine months ended September 30, 2025, revenues were
$14.1 million compared to$12.9 million in the same period in 2024, an increase of9.1% .Canadian Teleradiology Services, Inc., the Company's
100% owned subsidiary had EBITDA in the third quarter of$836,000. For the nine months ended September 30, 2025, Canadian Teleradiology Services, Inc. had EBITDA of
$3.04 million .
2025 Third Quarter Financial Results
Revenues of
$4.85 million in the third quarter of 2025 with a net loss of$(26,378) .EBITDA of
$600,677 for the third quarter of 2025.Revenues of
$14.1 million for the nine months ended September 30, 2025, with a net income of$5,754. EBITDA of
$1.90 million for the nine months ended September 30, 2025.
Previously Announced Acquisition
The Company entered into an agreement to acquire two additional diagnostic imaging outpatient clinics located in Calgary, Alberta. The transaction was not approved by one of the vendors landlords and the transaction has been terminated. See the Company's news release dated June 13, 2025.
Management Comments
Mitch Geisler, CEO, commented, "We are very pleased with our Q3 results and year-over-year growth. We continue to focus on increasing clinic revenue with additional patients scans and other organic growth opportunities including our preparations in Alberta to add mammography and increase our fluoroscopy and pain management services."
Non-IFRS Financial Measures
This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity.
For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the three months and nine months ended September 30, 2025, which are available on the Company's website (www.leveljumphealthcare.com) and under the Company's profile on SEDAR (www.sedarplus.ca).
About LevelJump Healthcare
LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve.
ON BEHALF OF THE BOARD OF DIRECTORS OF
LEVELJUMP HEALTHCARE CORP.
Mitchell Geisler
Chief Executive Officer
info@leveljumphealthcare.com
647-340-2020
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION
This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).
Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.
The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/273960
FAQ
What were LevelJump's Q3 2025 revenues and net income (JMPHF)?
How did LevelJump perform for the nine months ended September 30, 2025 (JMPHF)?
What EBITDA did Canadian Teleradiology Services report in Q3 2025?
Why was the acquisition of two Calgary clinics terminated?
Does LevelJump plan service expansions after Q3 2025?
